abstract |
The present invention provides a selection of compounds of formula (I); compositions comprising such compounds; the use of such compounds in therapy (eg, in the treatment or prevention of diseases or conditions in which plasma kallikrein activity is involved); and methods of treating a patient with a compound; wherein R5, R6, R7, A, B, W, X, Y and Z are as defined herein. |